CTTN and breast neoplasm: When we used cortactin and Tks5 as invadopodium markers in breast tumor cells, we found that knocking down PTP1B with siRNA increased invadopodium-associated ECM degradation and the number of mature invadopodia per cell (Supplementary Fig. S4).